BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22362966)

  • 1. Bovine viral diarrhea virus cyclically impairs long bone trabecular modeling in experimental persistently infected fetuses.
    Webb BT; Norrdin RW; Smirnova NP; Van Campen H; Weiner CM; Antoniazzi AQ; Bielefeldt-Ohmann H; Hansen TR
    Vet Pathol; 2012 Nov; 49(6):930-40. PubMed ID: 22362966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of in utero pestivirus infection on bovine fetal bone geometry, biomechanical properties and composition.
    Webb BT; McGilvray KC; Smirnova NP; Hansen TR; Norrdin RW
    Vet J; 2013 Nov; 198(2):376-81. PubMed ID: 24135548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fetal protection against continual exposure to bovine viral diarrhea virus following administration of a vaccine containing an inactivated bovine viral diarrhea virus fraction to cattle.
    Grooms DL; Bolin SR; Coe PH; Borges RJ; Coutu CE
    Am J Vet Res; 2007 Dec; 68(12):1417-22. PubMed ID: 18052749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HoBi-Like Virus RNA Detected in Foetuses Following Challenge of Pregnant Cows that had Previously Given Birth to Calves Persistently Infected with Bovine Viral Diarrhoea Virus.
    Bauermann FV; Falkenberg SM; Ridpath JF
    Transbound Emerg Dis; 2017 Oct; 64(5):1624-1632. PubMed ID: 27615437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of interferon-gamma and downstream pathways during establishment of fetal persistent infection with bovine viral diarrhea virus.
    Smirnova NP; Webb BT; McGill JL; Schaut RG; Bielefeldt-Ohmann H; Van Campen H; Sacco RE; Hansen TR
    Virus Res; 2014 Apr; 183():95-106. PubMed ID: 24530541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of modified-live bovine viral diarrhea virus vaccines containing either type 1 or types 1 and 2 BVDV on heifers and their offspring after challenge with noncytopathic type 2 BVDV during gestation.
    Ficken MD; Ellsworth MA; Tucker CM; Cortese VS
    J Am Vet Med Assoc; 2006 May; 228(10):1559-64. PubMed ID: 16677126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The fetal brain in bovine viral diarrhea virus-infected calves: lesions, distribution, and cellular heterogeneity of viral antigen at 190 days gestation.
    Montgomery DL; Van Olphen A; Van Campen H; Hansen TR
    Vet Pathol; 2008 May; 45(3):288-96. PubMed ID: 18487484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of fetal protection against experimental infection with type 1 and type 2 bovine viral diarrhea virus after vaccination of the dam with a bivalent modified-live virus vaccine.
    Fairbanks KK; Rinehart CL; Ohnesorge WC; Loughin MM; Chase CC
    J Am Vet Med Assoc; 2004 Dec; 225(12):1898-904. PubMed ID: 15643841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of fetal and placental innate immune responses during establishment of persistent infection with bovine viral diarrhea virus.
    Smirnova NP; Webb BT; Bielefeldt-Ohmann H; Van Campen H; Antoniazzi AQ; Morarie SE; Hansen TR
    Virus Res; 2012 Aug; 167(2):329-36. PubMed ID: 22659490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental infection of pregnant ewes with bovine viral diarrhea virus type-2 (BVDV-2): effects on the pregnancy and fetus.
    Scherer CF; Flores EF; Weiblen R; Caron L; Irigoyen LF; Neves JP; Maciel MN
    Vet Microbiol; 2001 Apr; 79(4):285-99. PubMed ID: 11267789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bovine viral diarrhea virus fetal persistent infection after immunization with a contaminated modified-live virus vaccine.
    Palomares RA; Marley SM; Givens MD; Gallardo RA; Brock KV
    Theriogenology; 2013 May; 79(8):1184-95. PubMed ID: 23561853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute non-cytopathic bovine viral diarrhea virus infection induces pronounced type I interferon response in pregnant cows and fetuses.
    Smirnova NP; Bielefeldt-Ohmann H; Van Campen H; Austin KJ; Han H; Montgomery DL; Shoemaker ML; van Olphen AL; Hansen TR
    Virus Res; 2008 Mar; 132(1-2):49-58. PubMed ID: 18053605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental persistent infection with bovine viral diarrhea virus in white-tailed deer.
    Passler T; Walz PH; Ditchkoff SS; Givens MD; Maxwell HS; Brock KV
    Vet Microbiol; 2007 Jun; 122(3-4):350-6. PubMed ID: 17353103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental fetal challenge using type II bovine viral diarrhea virus in cattle vaccinated with modified-live virus vaccine.
    Brock KV; Cortese VS
    Vet Ther; 2001; 2(4):354-60. PubMed ID: 19746658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of a dual fetal infection model with bovine viral diarrhoea viruses (BVDV)-1 and BVDV-2.
    Makoschey B; Janssen MG
    Arch Virol; 2011 Oct; 156(10):1831-3. PubMed ID: 21597952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fetal protection in heifers vaccinated with a modified-live virus vaccine containing bovine viral diarrhea virus subtypes 1a and 2a and exposed during gestation to cattle persistently infected with bovine viral diarrhea virus subtype 1b.
    Leyh RD; Fulton RW; Stegner JE; Goodyear MD; Witte SB; Taylor LP; Johnson BJ; Step DL; Ridpath JF; Holland BP
    Am J Vet Res; 2011 Mar; 72(3):367-75. PubMed ID: 21355740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of Bovine viral diarrhea virus 1 nucleic acid in fetal bovine samples stored under different conditions.
    Ridpath JF; Neill JD; Chiang YW; Waldbillig J
    J Vet Diagn Invest; 2014 Jan; 26(1):6-9. PubMed ID: 24352225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of persistent infection in calves by vaccination of dams with noncytopathic type-1 modified-live bovine viral diarrhea virus prior to breeding.
    Dean HJ; Hunsaker BD; Bailey OD; Wasmoen T
    Am J Vet Res; 2003 May; 64(5):530-7. PubMed ID: 12755290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against fetal infection with either bovine viral diarrhea virus type 1 or type 2 using a noncytopathic type 1 modified-live virus vaccine.
    Brock KV; McCarty K; Chase CC; Harland R
    Vet Ther; 2006; 7(1):27-34. PubMed ID: 16598681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of pregnant cattle and their fetuses against infection with bovine viral diarrhea virus type 1 by use of a modified-live virus vaccine.
    Cortese VS; Grooms DL; Ellis J; Bolin SR; Ridpath JF; Brock KV
    Am J Vet Res; 1998 Nov; 59(11):1409-13. PubMed ID: 9829398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.